Eyenovia Technology
The innovation behind Eyenovia “Making it Possible.”
The innovation behind Eyenovia “Making it Possible.”
Designed to be the easiest way to dispense eye drop medications to the eye. What once involved steady hand-eye coordination and tilting your head back has now become as simple as the push of a button. Benefit from your eye medication taken as a mist that coats the eye faster than you can blink without the frustration associated with traditional eye drops.
The Optejet® dispenser’s ease of use makes it great for both caregivers and self-administration. A recent clinical study showed that 95% of subject attempts at self-administering using the Optejet® were successful1. The same study also showed 96% of technician administrations using the Optejet® were successful on the first attempt1. Doctor’s offices and technicians might also benefit from the ease of use with shortened patient chair time leading to quicker office visits and allowing more patients to be cared for.
1. Rathi, S and Scott, B. 2020, May. Evaluation of Topical Ophthalmic Medication Administration Using a Microdose Dispenser ( MiDD ) in Multiple Controlled Clinical Trials.
Eyenovia’s Optejet® dispenser with MAP™ technology (Microdose Array Print) is a horizontal topical delivery system for the eye and works similar to an inkjet printer. Medication is administered as a directional mist in a micro droplet array, coating the corneal surface of the eye like pixels. Contact happens at low velocity minimizing ocular impact. Unlike a traditional eyedropper that uses gravity, the Optejet® dispenses medication horizontally. The Optejet® is designed to administer every dose reliably and accurately to someone who could be seated or standing.
Traditional eye drops that are approximately 40μL in volume exceed the absorption capacity of the eye which is approximately 8μL. This can lead to drug overflow and possible overdosing that exposes patients to excess drug and preservative2. With our MAP™ technology, delivered with the Optejet® dispenser, an 8μL dose of medication can be precisely misted onto the cornea with 80% less exposure to drug and preservative toxicity. Products delivered in the Optejet® have lower amounts of drug entering the blood stream with potentially fewer side effects on the eyes.
2. American Academy of Ophthalmology (AAO). “Wouldn’t it be great if eyedrops didn’t spill out of your eyes?.” ScienceDaily. ScienceDaily, 13 November 2017
Eyenovia is developing smart electronics inside the Optejet® and mobile e-health technology that may transform compliance and chronic disease management by empowering patients and physicians with access to real-time monitoring and compliance data for a more intelligent and personalized therapeutic paradigm.
Smart Monitoring – The Optejet® is designed to communicate with your smart device and track your dosing.
Set up your Alerts – Your Optejet® may be able to remind you when you need to dose or refill.
Share with Your Doctor – Potentially share information about your dosing with your doctor to improve treatment decisions.
[stock_market_widget type=”toast” template=”basic” assets=”EYEN” position=”bottomRight” transition_in=”flipInX” transition_out=”flipOutX” timeout=”5″ logo=”true” api=”yf”]